Bank Of Montreal »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bank Of Montreal

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Bank Of Montreal from 13F filings

Historical chart of Bank Of Montreal investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Bank Of Montreal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Bank Of Montreal

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.3M 9.4M 0.99
2023-09-30 $6.3M 6.5M 0.96

More positions owned by Bank Of Montreal

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Tesla Motors (TSLA)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bk Nova Cad (BNS)
Meta Platforms Cl A (META)
Cibc Cad (CM)
Bank Of Montreal Cadcom (BMO)
Walt Disney Company (DIS)

View all positions for Bank Of Montreal

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Steelhead Partners
Calamos Advisors
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1